Eun Joo Kang - Concepedia

Author

Eun Joo Kang

Korea University Medical Center ORCID

Also Known As

E J Kang, E Kang, E. J. KANG, E. J. Kang, E. Kang, E.J. Kang, EUN JOO KANG, Eun Joo Kang, Eun J. Kang, Eun Joo KANG

152

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Korea University Medical Center Seoul National University Hospital Korea University Seoul National University Bundang Hospital Sungkyunkwan University

About

Eun Joo Kang is an author at Korea University Medical Center specializing in medicine, pathology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.3K
2	Health Sciences	8	8	482
3	Nursing	2	2	65
4	Public Health	2	2	100
5	Allergy	1	1	55

Eun Joo Kang

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim, The Lancet Oncology MedicineImmunologyPathologyImmune Checkpoint InhibitorCancer Treatment	2018	568
Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) Jang Ho Cho, Sung Hee Lim, Ho Jung An, Journal of Clinical Oncology	2019	346
Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients E. J. Kim, S. S. Cho, Yong Jeong, Brain AgingNeurochemical BiomarkersLate OnsetMetabolic SyndromeAlzheimer's Disease	2005	231
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With <i>EGFR</i>- or <i>ALK</i>-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04) Sehhoon Park, Tae Min Kim, Ji‐Youn Han, Journal of Clinical Oncology	2023	141
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01) Yun‐Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, BMC Cancer	2020	68
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14‐01) Youjin Kim, Su Jin Lee, Ji Yun Lee, Cancer	2017	61
Priorities of a “good death” according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey Young Ho Yun, Kyoung‐Nam Kim, Jin-Ah Sim, Supportive Care in Cancer Family MedicineQuality Of LifeFamily HealthCancer EpidemiologyHealth Policy	2018	61
Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors Hyeyoon Chang, Jung Sun Kim, Yoon Ji Choi, OncoTargets and Therapy	2017	58
Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma Eun Joo Kang, Myung‐Ju Ahn, Chan-Young Ock, Clinical Cancer Research	2021	57
Frontal Dysfunction Underlies Depressive Syndrome in Alzheimer Disease: A FDG-PET Study Dong Young Lee, Il Han Choo, Jin Hyeong Jhoo, American Journal of Geriatric Psychiatry Alzheimer's DiseaseHealth SciencesPsychiatryDementiaSubcortical Ischemic Depression	2006	56

Page 1